Bristol-Myers Squibb Co. BMY
$62.48
+1.78%
at last close
Market Cap$127.71 billion
P/E Ratio—
Div Yield4.03%
Volume12.67M
52-Week Range
$42.52$68.64
Analyst Ratings
- Consensus
- Moderate Buy — 8 Buy · 8 Hold · 1 Sell (17 analysts)
- Avg. Price Target
- $65.00 (+4.0% upside)
Key Stats
- Today's Range
- $62.28 – $64.05
- 50-Day Range
- $56.15 – $68.24
- 52-Week Range
- $42.52 – $68.64
- Volume
- 12.67 million shs
- Average Volume
- 12.72 million shs
- Market Cap
- $127.71 billion
- P/E Ratio
- —
- Dividend Yield
- 4.03%
Dividend
- Dividend Yield
- 4.03%
- Annual Dividend
- $2.52
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-10-02
Short Interest
- Short Interest
- 0.39%
- Days to Cover
- 1.64
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Related Stocks
Compare head-to-head: BMY vs LLY·BMY vs JNJ·BMY vs ABBV·BMY vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.